secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2023-08-31T23:59:59+00:00
Accession:  0001493152-23-031359
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell closes spinout of BriaPro, distributes shares to existing shareholders
-------------------------------------------------------------------------------

- BriaCell completed spinout of BriaPro, receiving 2/3 ownership; shareholders get one BriaPro share and one new BriaCell share per old share.
- BriaPro acquired pipeline assets Bria-TILsRx™ and PKCδ inhibitors for cancer indications.
- New BriaCell common shares expected to begin trading on or about September 5, 2023 under symbol BCT.
- BriaCell remains listed on Nasdaq and TSX; BriaPro is an unlisted reporting issuer in Canada.
- Computershare will distribute certificates; letters of transmittal mailed to registered holders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223031359/0001493152-23-031359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315223031359/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-031359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer